Inflamase Forte®
Prednisolone Sodium Phosphate 1.0% · ophthalmic solution
Allergy, Steroid
Approved uses
Steroid-responsive anterior segment inflammation
One or two drops up to every hour by day and every two hours at night as necessary initially, reduced to one drop every four hours on response, then further reduction to one drop three to four times daily may suffice
Contraindications
- Acute superficial herpes simplex keratitis.
- Fungal diseases of ocular structures.
- Acute infectious stages of vaccinia, varicella, and most other viral diseases of the cornea and conjunctiva.
- Tuberculosis of the eye.
- Hypersensitivity to a component of this medication.
- Always contraindicated after uncomplicated removal of a superficial corneal foreign body.
1% solution (prednisolone sodium phosphate 10 mg/mL, equivalent to 9.1 mg/mL prednisolone phosphate), 10 mL bottle
Glucocorticoid that causes inhibition of the inflammatory response to inciting agents of mechanical, chemical, or immunological nature; the label states that no generally accepted explanation of this steroid property has been advanced.
Warnings & Precautions
- Not for injection into eye: For topical use only.
- Herpes simplex stromal keratitis: Steroid use where the stroma is involved requires great caution, and frequent slit lamp microscopy is mandatory.
- IOP elevation and glaucoma: Prolonged use may raise IOP and produce glaucoma, optic nerve damage, and defects in visual acuity and visual fields; check IOP frequently.
- Posterior subcapsular cataract: Prolonged use may produce it.
- Secondary ocular infection: Prolonged use may aid establishment of secondary ocular infection from pathogens liberated from ocular tissues, and acute purulent untreated infection of the eye may be masked or its activity enhanced.
- Corneal or scleral perforation: In diseases causing thinning of the cornea or sclera, perforation has occurred with topical steroids.
- Viral, bacterial, and fungal keratitis: Viral, bacterial, and fungal infections of the cornea may be exacerbated by steroid application. Fungal infections of the cornea are particularly prone to develop coincidentally with long-term steroid applications, so fungus invasion must be suspected in any persistent corneal ulceration where a steroid has been used or is in use.
- Mustard gas keratitis and Sjögren's keratoconjunctivitis: Not effective in either.
- Persistent irritation: If irritation persists or develops, the patient should be advised to discontinue use and consult the prescribing physician.
Common Side Effects
Adverse reactions include glaucoma with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infections from pathogens including herpes simplex and fungi, and perforation of the globe. Rarely, filtering blebs have been reported when topical steroids have been used following cataract surgery. Rarely, stinging or burning may occur.
Pregnancy: Animal reproductive studies have not been conducted. Whether the drug can cause fetal harm or affect reproductive capacity is unknown, as is its effect on the later growth, development, and functional maturation of the child; give during pregnancy only if clearly needed.
Lactation: Whether the drug is excreted in human milk is unknown; because many drugs are, use with caution in a nursing woman.
Safety and effectiveness in pediatric patients have not been established.